FDA Approves Novartis’ New IL-17A-Blocking Psoriasis Drug Cosentyx
Novartis' Cosentyx is the first approved human monoclonal antibody that selectively binds to interleukin IL-17A.
Tag: Novartis
All
LatestSorry, No Posts Found
All
Latest
Radiesse Has Been Shown to Boost Collagen and Elastin. New Research Suggests It May Also Help Address Sun-Damaged Skin
A study found increases in collagen, elastin, and other extracellular matrix proteins following Radiesse treatment, along with improvements in markers of solar elastosis, a sign of sun-damaged skin.
